NanoString Technologies | Des Atouts



Des Atouts Changement Date
Agilent USD 12.73B 501M 2025-09
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Bio Techne USD 2.52B 3.45M 2025-12
Bio-Rad Laboratories USD 10.58B 880.1M 2025-12
Bruker USD 6.24B 193.5M 2025-12
Charles River Laboratories USD 7.14B 378.39M 2025-12
Danaher USD 83.46B 3.57B 2025-12
Exact Sciences USD 5.86B 39.38M 2025-12
Hologic USD 9.18B 165.8M 2025-12
Illumina USD 6.64B 467M 2025-12
IQVIA Holdings USD 29.94B 1.22B 2025-12
Mettler Toledo International USD 3.71B 191.18M 2025-12
Myriad Genetics USD 728.1M 50.8M 2025-09
Pacific Biosciences Of California USD 803.16M 22.31M 2025-09
Repligen USD 2.92B 22.08M 2025-09
Revvity USD 12.17B 29.46M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Standard Biotools USD 539.64M 17.32M 2025-09
Thermo Fisher Scientific USD 110.34B 7.32B 2025-12
Waters USD 5.08B 221.41M 2025-12


NanoString Technologies Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.